Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

ClinicalTrials.gov ID: NCT05721235

Public ClinicalTrials.gov record NCT05721235. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Dose-Optimized, Open-Label, Safety/Tolerability and Pharmacokinetic Study With Azstarys® in Children 4 and 5 Years of Age With Attention-Deficit/Hyperactivity Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The is a multicenter, dose-optimized, open-label, safety/ tolerability and pharmacokinetic (PK) study with Azstarys® in children 4 and 5 years of age with attention-deficit/hyperactivity disorder (ADHD). The primary objective is to determine the safety and tolerability of treating children 4 and 5 years-of-age with ADHD with Azstarys® for up 12 months. Approximately 100 subjects will be enrolled. Approximately 20 sites will participate.

Study identification

NCT ID
NCT05721235
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Corium, Inc.
Industry
Enrollment
123 participants

Conditions and interventions

Eligibility (public fields only)

Age range
4 Years to 5 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2, 2023 (Actual)
Primary completion
Jul 31, 2025 (Actual)
Completion
Jul 31, 2025 (Actual)
Last update posted
May 8, 2026

2023 – 2025

United States locations

U.S. sites
20
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
Preferred Research Partners (PRP) Little Rock Arkansas 72211 —
Advanced Research Center (ARC) Anaheim California 92805 —
IMMUNOe International Research Center Centennial Colorado 80112 —
Clinical Neuroscience Solutions - Orlando Jacksonville Florida 32256 —
Accel Research Sites - Lakeland Lakeland Florida 33803 —
Accel Research Sites - Maitland Maitland Florida 32751 —
South Florida Research Phase I-IV INC Miami Springs Florida 33166 —
CNS Healthcare - Orlando Orlando Florida 32801 —
iResearch Atlanta Decatur Georgia 30030 —
CenExel iResearch, LLC Savannah Georgia 31405 —
Sky Clinical Research Network Group P.C. Union City Georgia 30291 —
DelRicht Research - Touro Medical Center New Orleans Louisiana 70115 —
St Charles Psychiatric Associates & Midwest Research Group Saint Charles Missouri 63304 —
Boeson Research Missoula Montana 59804 —
Alivation Research, LLC Lincoln Nebraska 68526 —
Center For Psychiatry and Behavioral Medicine Inc Las Vegas Nevada 89128 —
Clinical Neuroscience Solution, Inc Memphis Tennessee 38119 —
Houston Clinical Trials Bellaire Texas 77401 —
AIM Trials Plano Texas 75093 —
Flourish Research San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05721235, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 8, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05721235 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →